Literature DB >> 10953203

Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD.

O Combarros1, M Sánchez-Guerra, J Llorca, A Alvarez-Arcaya, J Berciano, N Peña, C Fernández-Viadero.   

Abstract

An association between cognitive performance in elderly people and variability in the codon 129 of the prion protein gene (PRNP) has been recently described. The authors analyzed this polymorphism in 278 sporadic AD patients and 268 cognitively normal control subjects. Analyses stratifying by APOE genotype, age, and gender failed to reveal any association between homozygosity for the 129 PRNP methionine or valine alleles and AD.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10953203     DOI： 10.1212/wnl.55.4.593

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  15 in total

1.  Genotype frequencies at codon 129 of the prion protein gene in Brazil: Implications in susceptibility to variant Creutzfeldt-Jakob disease compared to European and Asian populations.

Authors:  Erich Vinicius de Paula; Marcelo Addas-Carvalho; Devanira Souza Paixao Costa; Sara Terezinha Olalla Saad; Simone Cristina Olenscki Gilli
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Prion protein gene M129 allele is a risk factor for Alzheimer's disease.

Authors:  M Gacia; K Safranow; M Styczyńska; K Jakubowska; B Pepłońska; M Chodakowska-Zebrowska; I Przekop; A Słowik; E Golańska; K Hułas-Bigoszewska; D Chlubek; D Religa; C Zekanowski; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

3.  Analysis of PRNP gene codon 129 polymorphism in the Greek population.

Authors:  Angelica A Saetta; Nikolaos V Michalopoulos; George Malamis; Polyanthi I Papanastasiou; Niki Mazmanian; Maria Karlou; Anastasios Kouzoupis; Penelope Korkolopoulou; Efstratios Patsouris
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

4.  Interaction between prion protein and interleukin-1A genes increases early-onset Alzheimer's disease risk.

Authors:  Onofre Combarros; Javier Llorca; Pascual Sánchez-Juan; Ignacio Mateo; Jon Infante; Eloy Rodríguez; Coro Sánchez-Quintana; José Berciano
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

5.  Prnp gene and cerebellum volume in patients with refractory mesial temporal lobe epilepsy.

Authors:  Michelle N Valadão; Erica R Coimbra; Michele C Landemberger; Tonicarlo R Velasco; Vera C Terra; Lauro Wichert-Ana; Veriano Alexandre; David Araújo; Ricardo Guarnieri; Vilma R Martins; Antônio Carlos Santos; Américo C Sakamoto; Roger Walz
Journal:  Neurol Sci       Date:  2013-10-05       Impact factor: 3.307

6.  Inherited forms of Creutzfeldt-Jakob disease.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-04       Impact factor: 3.825

7.  Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation.

Authors:  A C Bruni; L Bernardi; R Colao; E Rubino; N Smirne; F Frangipane; B Terni; S A M Curcio; M Mirabelli; A Clodomiro; R Di Lorenzo; R Maletta; M Anfossi; M Gallo; S Geracitano; C Tomaino; M G Muraca; A Leotta; S G Lio; L Pinessi; I Rainero; S Sorbi; L Nee; G Milan; S Pappatà; A Postiglione; N Abbamondi; G Forloni; P St George Hyslop; E Rogaeva; O Bugiani; G Giaccone; J F Foncin; M G Spillantini; G Puccio
Journal:  Neurology       Date:  2010-02-17       Impact factor: 9.910

Review 8.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 9.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

10.  Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Alberto Rábano; Rafael Blesa; Teresa Gómez-Isla; Fernando Valdivieso; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.